Longevity swaps

Pensions are too complicated a topic for political parties to discuss in any detail on the general election campaign trail, a majority of this week’s 110 Pensions Buzz respondents said.

There are a wide range of possible life expectancy disruptors. PwC's Paul Kitson looks at how one of these, wearables, could impact schemes.

Around £17.5bn of buy-ins and buyouts were transacted in the first half of the year as market records continue to tumble.

The HSBC Bank (UK) Pension Scheme has hedged its longevity risk with Prudential Insurance Company of America (PICA) in the second-largest ever deal of its type.

Tendencies to prefer the status quo and familiar names can result in slower or more irrational decisions, Aon says. James Phillips explores the impediments to risk settlement.

Robert Wagstaff and Caroline Cruickshank assess the benefits of using third-parties to help manage longevity swap valuation and collateralisation

Longevity hedges have long been considered a hurdle to doing a bulk annuity, but a ground-breaking deal shows it doesn't have to be. Stephanie Baxter looks at why converting swaps into buy-ins is taking off.

Mortality improvements have declined for yet another year, ducking previous estimates. James Phillips explores what this means for pension schemes

Phoenix Life has announced it completed a buy-in for its UK defined benefit (DB) scheme last December, making it the largest de-risking transaction of the year.

Aon Hewitt is reiterating its call for pension schemes to review the emerging lower rates of UK mortality improvement to ensure fair pricing of longevity insurance transactions.